A new trading day began on Friday, with Tyra Biosciences Inc (NASDAQ: TYRA) stock price up 10.96% from the previous day of trading, before settling in for the closing price of $22.99. TYRA’s price has ranged from $6.42 to $24.05 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -73.69% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -30.88%. With a float of $36.43 million, this company’s outstanding shares have now reached $53.32 million.
Tyra Biosciences Inc (TYRA) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Tyra Biosciences Inc is 31.68%, while institutional ownership is 75.19%. The most recent insider transaction that took place on Dec 19 ’25, was worth 250,000. In this transaction Director of this company sold 10,000 shares at a rate of $25.00, taking the stock ownership to the 3,823,425 shares. Before that another transaction happened on Dec 12 ’25, when Company’s Chief Discovery Officer sold 8,000 for $22.64, making the entire transaction worth $181,159. This insider now owns 162,981 shares in total.
Tyra Biosciences Inc (TYRA) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.43 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.57 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -30.88% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -14.56% during the next five years compared to -73.69% drop over the previous five years of trading.
Tyra Biosciences Inc (NASDAQ: TYRA) Trading Performance Indicators
Here are Tyra Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 17.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.88, a number that is poised to hit -0.53 in the next quarter and is forecasted to reach -2.21 in one year’s time.
Technical Analysis of Tyra Biosciences Inc (TYRA)
Let’s dig in a bit further. During the last 5-days, its volume was 0.72 million. That was better than the volume of 0.32 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 63.91%.
During the past 100 days, Tyra Biosciences Inc’s (TYRA) raw stochastic average was set at 97.68%, which indicates a significant increase from 93.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.39 in the past 14 days, which was higher than the 0.95 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.01, while its 200-day Moving Average is $12.47. However, in the short run, Tyra Biosciences Inc’s stock first resistance to watch stands at $26.59. Second resistance stands at $27.68. The third major resistance level sits at $29.47. If the price goes on to break the first support level at $23.71, it is likely to go to the next support level at $21.92. Assuming the price breaks the second support level, the third support level stands at $20.83.
Tyra Biosciences Inc (NASDAQ: TYRA) Key Stats
With a market capitalization of 1.36 billion, the company has a total of 53,372K Shares Outstanding. Currently, annual sales are 0 K while annual income is -86,480 K. The company’s previous quarter sales were 0 K while its latest quarter income was -29,870 K.
